These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22718305)

  • 1. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience.
    Bratincsák A; Moore JW; El-Said HG
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):782-5. PubMed ID: 22718305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy using a low dose of tissue plasminogen activator in children.
    Santiago MJ; Lopez-Herce J; Del Castillo DB
    Catheter Cardiovasc Interv; 2014 Feb; 83(2):339-40. PubMed ID: 24123670
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic therapy for femoral artery thrombosis after left cardiac catheterization in children.
    Liu Q; Yan CW; Zhao SH; Jiang SL; Xu ZY; Huang LJ; Ling J; Zheng H; Wang Y
    Chin Med J (Engl); 2009 Apr; 122(8):931-4. PubMed ID: 19493417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen level as a surrogate for the outcome of thrombolytic therapy using tissue plasminogen activator for acute lower extremity intravascular thrombosis.
    Skeik N; Gits CC; Ehrenwald E; Cragg AH
    Vasc Endovascular Surg; 2013 Oct; 47(7):519-23. PubMed ID: 23899656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute iliofemoral venous thrombosis in patients with atresia of the inferior vena cava can be treated successfully with catheter-directed thrombolysis.
    Broholm R; Jørgensen M; Just S; Jensen LP; Bækgaard N
    J Vasc Interv Radiol; 2011 Jun; 22(6):801-5. PubMed ID: 21459610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long sheath use in femoral artery catheterizations in infants <15 kg is associated with a higher thrombosis rate: Proposed Protocol for Detection and Management.
    Ding L; Pockett C; Moore J; El-Said H
    Catheter Cardiovasc Interv; 2016 Dec; 88(7):1108-1112. PubMed ID: 27527119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Level and Bleeding Risk During Catheter-Directed Thrombolysis Using Tissue Plasminogen Activator.
    Lee K; Istl A; Dubois L; DeRose G; Forbes TL; Wiseman D; Mujoomdar A; Kribs S; Power AH
    Vasc Endovascular Surg; 2015 Oct; 49(7):175-9. PubMed ID: 26462979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.
    Gupta AA; Leaker M; Andrew M; Massicotte P; Liu L; Benson LN; McCrindle BW
    J Pediatr; 2001 Nov; 139(5):682-8. PubMed ID: 11713447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis.
    Baekgaard N; Broholm R; Just S; Jørgensen M; Jensen LP
    Eur J Vasc Endovasc Surg; 2010 Jan; 39(1):112-7. PubMed ID: 19879780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter thrombolysis with high-dose bolus tissue plasminogen activator in iatrogenic arterial occlusion after femoral arterial catheterization.
    Tsetis DK; Kochiadakis GE; Hatzidakis AA; Skalidis EI; Chryssou EG; Tritou IN; Vardas PE; Gourtsoyiannis NC
    Cardiovasc Intervent Radiol; 2002; 25(1):36-41. PubMed ID: 11907772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions.
    Sugimoto K; Hofmann LV; Razavi MK; Kee ST; Sze DY; Dake MD; Semba CP
    J Vasc Surg; 2003 Mar; 37(3):512-7. PubMed ID: 12618684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study.
    De Santis A; Moscatelli R; Catalano C; Iannetti A; Gigliotti F; Cristofari F; Trapani S; Attili AF
    Dig Liver Dis; 2010 Jun; 42(6):451-5. PubMed ID: 19819770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of periprocedural hypertension and adverse outcomes in patients undergoing catheter-directed thrombolysis.
    Agle SC; McNally MM; Powell CS; Bogey WM; Parker FM; Stoner MC
    Ann Vasc Surg; 2010 Jul; 24(5):609-14. PubMed ID: 20413257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endovascular venous thrombolysis in children younger than 24 months.
    Kukreja KU; Lungren MP; Patel MN; Johnson ND; Racadio JM; Dandoy C; Tarango C
    J Vasc Interv Radiol; 2014 Aug; 25(8):1158-64. PubMed ID: 24909354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of recombinant tissue plasminogen activator for venous thrombosis after paediatric heart surgery.
    Justice LB; Nelson DP; Palumbo J; Sawyer J; Patel MN; Byrnes JW
    Cardiol Young; 2018 Feb; 28(2):214-221. PubMed ID: 28889818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of tissue plasminogen activator for femoral artery thrombosis following transcatheter coil occlusion of patent ductus arteriosus.
    Carlson KM; Rutledge JM; Parker BR; Grifka RG
    Pediatr Cardiol; 2005; 26(1):83-6. PubMed ID: 15793657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant tissue plasminogen activator for the management of intracardiac thrombi in newborns].
    Álvarez Z P; Verdugo L P; Carvajal K L; Múhlhausen M G; Ríos A P; Rodríguez V D
    Rev Chil Pediatr; 2015; 86(3):194-9. PubMed ID: 26235268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fibrinolytic therapy for femoral artery thrombosis after left cardiac catheterization in children].
    Yan CW; Zhao SH; Jiang SL; Xu ZY; Ling J; Zheng H; Zhang GJ; Liu Q; Wang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jun; 38(6):518-21. PubMed ID: 21033133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.
    El-Segaier M; Khan MA; Khan ZU; Momenah T; Galal MO
    Pediatr Cardiol; 2015 Dec; 36(8):1582-7. PubMed ID: 25991571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk of renal dysfunction with percutaneous mechanical thrombectomy compared with catheter-directed thrombolysis.
    Morrow KL; Kim AH; Plato SA; Shevitz AJ; Goldstone J; Baele H; Kashyap VS
    J Vasc Surg; 2017 May; 65(5):1460-1466. PubMed ID: 27876521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.